Inherited dementia testing: a personal decision, not a universal lifespan forecast

A woman interviewed for the published report's Life Changing programme has described how deciding to learn whether she carried an inherited cause of early-onset Alzheimer's disease changed her plans and relationships. The account, reported by the published report, is about predictive testing in a family affected by a rare form of dementia. It is not a test that can tell every person how long they will live.

Her father developed symptoms at about 40. She left university to help care for him, and after losing both parents eventually moved to Melbourne. She told the programme that a specialist discussed her own inherited risk in 2013. In the family account, the possibility of inheriting the relevant change was one in two. That figure describes this kind of familial inheritance, not the dementia risk of everyone with an affected parent.

The decision was not immediate. She described six months of genetic counselling before testing and a six-week wait for the result. Learning that she carried the change was followed by shock, anger and a period of uncertainty about how to continue ordinary life. She later returned to Britain to be closer to her sister and took part in research. These are her personal recollections of the process, not a promise that every service uses the same timetable.

At 43, she said she was approaching the age range in which clinicians had discussed possible symptoms, but the story does not establish an exact date of onset or death. She described difficult decisions about telling new partners and about having children, while valuing time with loved ones and in nature. Her reproductive choice is a personal one, not a recommendation for other people with genetic risk. The report also describes hope, affection and research participation rather than treating a genetic result as the whole of a person's life.

A rare inherited change is not the same as a risk marker

Alzheimer's Society's published guidance distinguishes a disease-causing single-gene change from risk variants such as APOE4. In most families, dementia is not caused by a single-gene change. Testing for an APOE risk variant does not tell someone with certainty whether they will develop dementia. Predictive testing for an already identified familial change is a different clinical question and is assessed through specialist genetics services with counselling before and after testing.

The same guidance says that a negative result for one familial change does not rule out every other cause of dementia. It also cautions against direct-to-consumer dementia risk tests, which may be less reliable and lack professional support. A person worried about a strong family history can discuss it with a clinician rather than infer their own future from this story. The reported test-accuracy claim in an individual's account should not be used as an advertised accuracy figure for all genetic tests or as a lifespan forecast.